CVS Health Co. (NYSE:CVS) Shares Sold by Groupama Asset Managment

Groupama Asset Managment trimmed its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 25.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 59,697 shares of the pharmacy operator's stock after selling 20,410 shares during the quarter. Groupama Asset Managment's holdings in CVS Health were worth $2,623,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in CVS. Legacy Investment Solutions LLC bought a new stake in CVS Health during the third quarter valued at about $31,000. Ridgewood Investments LLC grew its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new stake in CVS Health in the 4th quarter worth approximately $28,000. Hopwood Financial Services Inc. purchased a new position in CVS Health during the fourth quarter valued at approximately $29,000. Finally, Financial Perspectives Inc boosted its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after purchasing an additional 466 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CVS has been the topic of several recent analyst reports. Leerink Partnrs upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Barclays boosted their price objective on CVS Health from $71.00 to $73.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Truist Financial lifted their target price on CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Piper Sandler upped their price target on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research note on Friday, March 21st. Finally, UBS Group reduced their price objective on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 11th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $70.39.

Remove Ads

CVS Health Trading Down 5.9 %

Shares of NYSE CVS traded down $3.97 during midday trading on Friday, hitting $63.54. The company's stock had a trading volume of 13,291,234 shares, compared to its average volume of 11,586,970. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The business's 50 day moving average is $63.47 and its two-hundred day moving average is $58.01. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $74.85. The firm has a market cap of $80.11 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.19%. CVS Health's payout ratio is 72.68%.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney bought 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.